机械通气患者的呼吸道微生物组:一篇叙述性综述
本文为叙述性综述,总结机械通气ICU患者呼吸道微生物组研究现状。呼吸道微生物组研究少于肠道微生物组,侵入性通气患者研究少、仅小队列结果发表。下呼吸道与口咽部菌群存在重叠,菌群含常规方法难培养的丰富细菌。机械通气下出现菌群失调、多样性随时间下降。VAP发生时肺部菌群向单一优势病原体(主要为变形菌门)转变;ARDS患者则以肠道相关细菌(主要为肠杆菌科)富集为特异性鉴别特征。菌群失调在VAP和ARDS发病中的作用尚未完全明确,作者提出应优先验证共识性稳健方法学并开展纵向研究。
要点
- 机械通气患者呼吸道微生物组发生菌群失调,多样性随时间下降。
- VAP发展时肺部菌群失调以向单一优势细菌病原体(主要为变形菌门)转变為特征。
- ARDS患者的特异性鉴别特征是肠道相关细菌(主要为肠杆菌科)富集。
- 下呼吸道与口咽部观察到的细菌种群存在重叠,且菌群含常规方法难培养的较丰富细菌。
- 菌群失调在VAP和ARDS发病中的作用尚未完全明确,作者认为应优先验证共识性稳健方法学并开展纵向研究。
适用人群与场景
- 接受侵入性机械通气的ICU患者。
研究设计与关键结果
- 综述指出呼吸道微生物组研究少于肠道微生物组,侵入性通气ICU患者研究少,仅小队列结果发表。
- 下呼吸道与口咽部观察到的细菌种群存在重叠,细菌微生物组以常规方法难培养的较丰富细菌为特征。
- 机械通气下发生菌群失调,多样性随时间下降。
- VAP发展时肺部菌群失调以向单一优势细菌病原体(主要为变形菌门)转变为特征。
- ARDS患者以肠道相关细菌(主要为肠杆菌科)富集为特异性鉴别特征。
- 菌群失调在VAP和ARDS发病中的作用尚未完全明确。
证据类型、等级与局限
- 证据类型:叙述性综述。
- 局限:原文指出呼吸道微生物组研究少于肠道微生物组,侵入性通气ICU患者研究少,仅小队列结果发表;菌群失调在VAP和ARDS发病中的作用尚未完全明确。
对床旁实践的改变
- 作者认为,更深入分析细菌、病毒和真菌之间的相互作用并更好理解宿主-微生物组相互作用,可提供微生物组在VAP和ARDS发病中作用的更全面视角。
- 作者认为,应优先验证共识性稳健的呼吸道微生物组研究方法并开展纵向研究。
- 作者认为,更深入理解微生物间相互作用应成为ARDS和VAP预防/治疗策略管理的 valuable guide。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The respiratory microbiome has been less explored than the gut microbiome. Despite the speculated importance of dysbiosis of the microbiome in ventilator-associated pneumonia (VAP) and acute respiratory distress syndrome (ARDS), only few studies have been performed in invasively ventilated ICU patients. And only the results of small cohorts have been published. An overlap exists between bacterial populations observed in the lower respiratory tract and the oropharyngeal tract. The bacterial microbiota is characterized by relatively abundant bacteria difficult to cultivate by standard methods. Under mechanical ventilation, a dysbiosis occurs with a drop overtime in diversity. During VAP development, lung dysbiosis is characterized by a shift towards a dominant bacterial pathogen (mostly Proteobacteria) whereas enrichment of gut-associated bacteria mainly Enterobacteriaceae is the specific feature discriminating ARDS patients. However, the role of this dysbiosis in VAP and ARDS pathogenesis is not yet fully understood. A more in-depth analysis of the interplay between bacteria, virus and fungi and a better understanding of the host-microbiome interaction could provide a more comprehensive view of the role of the microbiome in VAP and ARDS pathogenesis. Priority should be given to validate a consensual and robust methodology for respiratory microbiome research and to conduct longitudinal studies. A deeper understanding of microbial interplay should be a valuable guide for care of ARDS and VAP preventive/therapeutic strategies. We present a review on the current knowledge and expose perspectives and potential clinical applications of respiratory microbiome research in mechanically ventilated patients.
参考来源
- Fromentin M, Ricard JD, Roux D, et al. Respiratory microbiome in mechanically ventilated patients: a narrative review. Intensive Care Med. 2021. PMID: 33559707. doi:10.1007/s00134-020-06338-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。